REBLOZYL Trademark
REBLOZYL is a USPTO trademark filed by Celgene Corporation. Status: Registered.
Trademark Facts
| Mark | REBLOZYL |
|---|---|
| Serial Number | 87329959 |
| Registration Number | 5321484 |
| Status | Registered |
| Filing Date | 2017-02-09 |
| Registration Date | 2017-10-31 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Celgene Corporation |
| Attorney of Record | Marilyn F. Kelly |
| Prosecution Events | 32 |
| Latest Event | APRE on 2024-03-28 |
Goods & Services
Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system